Production (Stage)
Jolt Health Inc.
JOLT
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 686.96% | 48.01% | 68.17% | -22.47% | -126.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 686.96% | 48.01% | 68.17% | -22.47% | -126.59% |
| Operating Income | -686.96% | -48.01% | -68.17% | 22.47% | 126.59% |
| Income Before Tax | -121.93% | -139.62% | -34.87% | 26.10% | 86.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -121.93% | -139.62% | -34.87% | 26.10% | 86.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -121.93% | -139.62% | -34.87% | 26.10% | 86.25% |
| EBIT | -686.96% | -48.01% | -68.17% | 22.47% | 126.59% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -35.04% | -15.94% | 43.23% | 53.14% | 88.02% |
| Normalized Basic EPS | -483.56% | -16.28% | 43.35% | 53.03% | 110.04% |
| EPS Diluted | -35.04% | -15.94% | 43.23% | 53.14% | 88.02% |
| Normalized Diluted EPS | -483.56% | -16.28% | 43.35% | 53.03% | 110.04% |
| Average Basic Shares Outstanding | 64.51% | 108.39% | 137.93% | 57.65% | 14.70% |
| Average Diluted Shares Outstanding | 64.51% | 108.39% | 137.93% | 57.65% | 14.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |